Lilly Just Took Major Steps Forward in Obesity Drug Market
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
Why Should I Choose Zero Based Budgeting outlines the benefits of a zero-first approach, including enhanced visibility and purposeful spending. Consider adopting it to simplify money decisions.
26,489 articlesTwo bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
The POWI 2026 earnings transcript sheds light on how the company performed in Q1 and what the path ahead could look l...
Here Group's Q3 2026 earnings reveal where the company is growing and where risks lurk. This article breaks down the ...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Step into the 2026 beauty health (skin) investing landscape. This guide translates early 2026 earnings signals into a...
Massive passive flows into the Russell 2000 through IWM are lifting small caps, even as investors await the next Fed ...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
A renowned remote-work strategist warns that the 2026 labor market remains tight and cautious. Workers tied to curren...
First Advantage stock is climbing today as investors react to better-than-expected results and a growing AI-focused d...
Income investors are eyeing a familiar Dividend King delivering a near-3% yield. This article breaks down what that s...
A SpaceX public listing could ripple across technology, energy, and investing. Learn how NuScale Power stands to gain...
As Palantir rolls out its Agentic AI Platform, analysts clash over value. This article breaks down the upside, the ri...